Français
ItalianoBond BayUS Finance 0% ( USU07264AC54 ) in USD
| Issuer | BayUS Finance |
| Market price | 100 % ⇌ |
| Country |  United States
|
| ISIN code |
 USU07264AC54 ( in USD )
|
| Interest rate | 0% |
| Maturity | 06/10/2017 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 400 000 000 USD |
| Cusip | U07264AC5 |
| Standard & Poor's ( S&P ) rating | NR |
| Moody's rating | NR |
| Detailed description |
Bayer US Finance is the finance function for Bayer's U.S. operations, responsible for all financial aspects including accounting, financial planning & analysis, treasury, tax, and internal audit. This article details the characteristics of a specific bond issuance from Bayer US Finance, a U.S.-based financing arm of the global life sciences company Bayer AG, which has reached its maturity and been fully redeemed. Identified by ISIN USU07264AC54 and CUSIP U07264AC5, this obligation was issued in the United States, denominated in USD, with a total issue size of $400,000,000 and a minimum purchase increment of $2,000. Notably, the bond carried a 0% interest rate and specified a payment frequency of 2, typically implying semi-annual payments, a characteristic that, combined with the zero interest, points to a specific financial structure such as a zero-coupon instrument issued at a discount. The bond matured on October 6, 2017, at which point it was redeemed at 100% of its par value, consistent with its full repayment. Both Standard & Poor's and Moody's designated this particular bond as "NR" (Not Rated). |